Aduro Biotech Announces First Patient Dosed in Phase 1 Study of ADU-214 for the Treatment of Lung Cancer

… therapy for the treatment of lung cancer, with the dosing of the … 400,000 people living with lung cancer in the United States alone … advanced or metastatic non-small cell lung cancer. The trial is expected to … epacadostat)), ADU-623 (brain cancer) ADU-214 (lung cancer, licensed to Janssen Biotech, Inc …